Prevalence of Function-Limiting Late Effects in Hodgkin Lymphoma Survivors
Nabela Enam, Kathy Chou, Michael D. Stubblefield
doi: https://doi.org/10.1101/2020.10.02.20202408
Nabela Enam
1Department of Physical Medicine & Rehabilitation, Rutgers New Jersey Medical School, Newark, NJ, USA
Kathy Chou
1Department of Physical Medicine & Rehabilitation, Rutgers New Jersey Medical School, Newark, NJ, USA
Michael D. Stubblefield
2Kessler Institute for Rehabilitation, West Orange, NJ, USA; Department of Physical Medicine & Rehabilitation, Rutgers New Jersey Medical School, Newark, NJ, USA

Article usage
Posted October 05, 2020.
Prevalence of Function-Limiting Late Effects in Hodgkin Lymphoma Survivors
Nabela Enam, Kathy Chou, Michael D. Stubblefield
medRxiv 2020.10.02.20202408; doi: https://doi.org/10.1101/2020.10.02.20202408
Subject Area
Subject Areas
- Addiction Medicine (230)
- Allergy and Immunology (507)
- Anesthesia (111)
- Cardiovascular Medicine (1264)
- Dermatology (148)
- Emergency Medicine (283)
- Epidemiology (10056)
- Gastroenterology (502)
- Genetic and Genomic Medicine (2486)
- Geriatric Medicine (240)
- Health Economics (482)
- Health Informatics (1653)
- Health Policy (757)
- Hematology (250)
- HIV/AIDS (538)
- Medical Education (255)
- Medical Ethics (75)
- Nephrology (269)
- Neurology (2304)
- Nursing (140)
- Nutrition (354)
- Oncology (1259)
- Ophthalmology (377)
- Orthopedics (134)
- Otolaryngology (226)
- Pain Medicine (158)
- Palliative Medicine (50)
- Pathology (326)
- Pediatrics (737)
- Primary Care Research (282)
- Public and Global Health (4850)
- Radiology and Imaging (846)
- Respiratory Medicine (657)
- Rheumatology (289)
- Sports Medicine (228)
- Surgery (273)
- Toxicology (44)
- Transplantation (131)
- Urology (100)